Short answer · Medically reviewed summary · Last updated: 2026-05-08
Multiple Systems Atrophy (MSA) is a progressive neurodegenerative disorder with a variable prognosis, typically involving a decline in motor and autonomic functions over several years. While there is currently no cure, proactive management of symptoms like orthostatic hypotension and urinary retention significantly improves daily comfort and quality of life for those living with Multiple Systems Atrophy. What is the typical prognosis for Multiple Systems Atrophy? The prognosis for Multiple Systems Atrophy varies significantly between individuals.
2 people with Multiple Systems Atrophy have shared their first-person experience on this question at DiseaseMaps.
Multiple Systems Atrophy prognosis
Prognosis of Multiple Systems Atrophy: quality of life, limitations and outlook, from research and from people who live with it.
Multiple Systems Atrophy (MSA) is a progressive neurodegenerative disorder with a variable prognosis, typically involving a decline in motor and autonomic functions over several years. While there is currently no cure, proactive management of symptoms like orthostatic hypotension and urinary retention significantly improves daily comfort and quality of life for those living with Multiple Systems Atrophy.
What is the typical prognosis for Multiple Systems Atrophy?
The prognosis for Multiple Systems Atrophy varies significantly between individuals. On average, the disease follows a progressive course over 6 to 10 years after the onset of motor symptoms. Because Multiple Systems Atrophy affects the autonomic nervous system, the heart, and the brain, the progression can be complex. However, early diagnosis and a multidisciplinary care team can help manage the impact of the disease on the nervous and circulatory systems.
How do subtypes and age of onset influence progression?
Multiple Systems Atrophy is generally classified into two subtypes: MSA-P (Parkinsonian features) and MSA-C (cerebellar features). Prognosis can be influenced by:
- Age of onset: Earlier onset is sometimes associated with a slightly longer, albeit still challenging, disease course.
- Subtype: MSA-C may present with more pronounced balance and coordination issues, while MSA-P often presents with more rigid, Parkinson-like motor symptoms.
- Autonomic severity: Early and severe orthostatic hypotension or central sleep apnea can complicate the clinical picture.
What complications should be monitored in Multiple Systems Atrophy?
Patients with Multiple Systems Atrophy require regular monitoring to address potential complications, including:
- Falls: Due to balance issues and sudden drops in blood pressure (orthostatic hypotension).
- Respiratory distress: Including vocal cord stridor, which requires specialized evaluation.
- Urinary complications: Chronic retention often requires proactive urological management to prevent infections.
- Sleep disturbances: Central sleep apnea is a common, serious concern that warrants routine sleep studies.
How can quality of life be maximized?
Modern care for Multiple Systems Atrophy focuses on "symptom-targeted" therapy. Physical, occupational, and speech therapy are essential to maintain function. With over 911 members in the DiseaseMaps.org community, patients are finding that connecting with others helps navigate the emotional and practical challenges of this diagnosis.
Next steps
- Consult a neurologist specializing in movement disorders to create a personalized management plan.
- Prioritize safety by installing grab bars and using mobility aids to prevent falls.
- Join the DiseaseMaps.org community to share experiences with others managing Multiple Systems Atrophy.
- Discuss advanced care planning and supportive palliative care early to ensure your preferences are documented.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult your physician for diagnosis and treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Multiple System Atrophy
- Orphanet: Multiple System Atrophy (ORPHA:587)
- The MSA Coalition: Understanding Symptom Management
- PubMed: "Clinical features and prognosis of Multiple System Atrophy"
Posted Mar 24, 2018 by [email protected] 3020
For MSA patients, one common symptom is low blood pressure when standing (Neurogenic Orthostatic Hypotension) which leads to passing out and injury from falls. There are several drugs that are often prescribed to MSA patients for this symptom. Florinef, Midodrine and Droxidopa are the most common ones. Each of these work slightly differently in the body in order to cause an increase in blood pressure. There are also non-pharmaceutical interventions that can raise blood pressure such as quickly drinking 16 oz of water in the morning before getting out of bed and eating a high salt diet.
Diligent attention to symptom management such as interventions to keep blood pressure from going too low when standing, using a walking aide or wheelchair to prevent falls, staying well hydrated to prevent urinary tract infections, speech and swallowing therapy to avoid choking which might lead to lung infections (pneumonia), physical therapy and exercise to maintain mobility. These efforts can all contribute to increased quality of life and possibly increased life expectancy although there is very little scientific data available to support this.
Posted Mar 31, 2018 by Pam Bower 2952
